Galera Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Malvern, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Galera Therapeutics, Inc. has filed 373 SEC EDGAR filings since 10 Dec 2012

SEC filing history

Showing 1-25 of 373 matching filings.

Per page
25
Current page
1
SCHEDULE 13G/A File 005-91201

SCHEDULE 13G/A filing

Filing date
14 Aug 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-251061

EFFECT filing

Filing date
07 Aug 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Aug 2026
Reporting date
03 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Aug 2026
Reporting date
03 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Aug 2026
Reporting date
15 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Aug 2026
Reporting date
03 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Aug 2026
Reporting date
03 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Aug 2026
Reporting date
15 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
15-12G File 001-39114

15-12G

Filing date
04 Aug 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-251061

POS AM

Filing date
04 Aug 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-271837

S-8 POS

Filing date
04 Aug 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-234607

S-8 POS

Filing date
04 Aug 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14C File 001-39114

DEFA14C

Filing date
13 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14C File 001-39114

DEFA14C

Filing date
07 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFM14C File 001-39114

DEFM14C

Filing date
02 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D File 005-91201

SCHEDULE 13D filing

Filing date
11 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-39114

425

Filing date
02 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-39114

425

Filing date
02 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-91201

SCHEDULE 13D/A filing

Filing date
29 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
29 May 2026
Reporting date
15 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-39114

425

Filing date
22 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .